beta-alanine has been researched along with Experimental Mammary Neoplasms in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tumors are visible as early as 0." | 1.32 | Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. ( Barrett, J; Bartis, J; Bozarth, J; Edwards, S; Ellars, C; Harris, TD; Kalogeropoulos, S; Lazewatsky, J; Liu, S; Nguyen, T; Onthank, D; Robinson, S; Silva, P; Yalamanchili, P, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, TD | 1 |
| Kalogeropoulos, S | 1 |
| Nguyen, T | 1 |
| Liu, S | 1 |
| Bartis, J | 1 |
| Ellars, C | 1 |
| Edwards, S | 1 |
| Onthank, D | 1 |
| Silva, P | 1 |
| Yalamanchili, P | 1 |
| Robinson, S | 1 |
| Lazewatsky, J | 1 |
| Barrett, J | 1 |
| Bozarth, J | 1 |
1 other study available for beta-alanine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Topics: Adenocarcinoma; Animals; beta-Alanine; Binding, Competitive; Cell-Matrix Junctions; Dose-Response Re | 2003 |